Trial | NCT02680275  Report issue

Title

Efficacy of Dead Sea Peloid Gel in Chronic Endometritis
Efficacy of Intravaginal Dead Sea Peloid Gel Administration in Complex Treatment of Chronic Endometritis and Reproductive Disorders: Randomized Placebo-controlled Prospective Study

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    30
This study evaluates the effect of Dead Sea Peloid Gel in the treatment of Chronic Endometritis in women with reproductive disorders. Half of participants will receive Dead Sea Peloid Gel and antibiotics, while the other half will receive Placebo Gel and antibiotics.

Patients with reproductive disorders who visited Research Medical Center of Family Health Problems and Human Reproduction were recruited.
Dead Sea Peloid Gel achieves improvement of blood circulation and receptor sensitivity of endometrium.
Study Started
Jul 31
2011
Primary Completion
Jun 30
2013
Study Completion
Jun 30
2013
Last Update
Feb 11
2016
Estimate

Drug Dead Sea Peloid Gel

intravaginally

  • Other names: Placebo Gel

Doxycycline,Dead Sea Peloid Gel,placebo Experimental

Group -1 stage: Doxycycline 100mg 2 times per day 10 days; followed by Dead Sea Peloid Gel , 60 ml per day fo 12 days, intravaginally Group -1 stage: Doxycycline 100mg 2 times per day 10 days; followed by placebo gel, 60 ml per day fo 12 days, intravaginally

Criteria 

Inclusion Criteria:

Women with miscarriage associated with chronic endometritis
Women without mental disorders able to swallow tablets

Exclusion Criteria: Clinical diagnosis of:

sexually transmitted diseases
endometrium hyperplasia and/or polyps
uterina fibroids
endocrine disorders
trombophilia
No Results Posted